The Pharmacy Times® Immunization resource center provides the latest news in immunization. Here, you’ll find information about upcoming conferences and meetings, updated clinical trial listings, and other resources for those interested in vaccination.
Although most children admitted to pediatric ICUs for COVID-19 had underlying conditions, children, teens, and young adults are at a greater risk for severe complications than researchers had previously believed.
Positive interim clinical data of the mRNA-1273 vaccine (Moderna, Inc) against the coronavirus disease 2019 were reported from a phase 1 study led by the National Institute of Allergy and Infectious Diseases.
Idaho, Rhode Island, and Utah allow them to perform this task. Which states are next?
The Pharmacy Times® Immunization resource center acts as a hub for all the latest clinical information pertaining to vaccines, with articles covering live-attenuated vaccines; inactivated vaccines; subunit, recombinant, polysaccharide; and conjugate vaccines. Here, pharmacists will find content surrounding the data from all phases of clinical trials and studies in the immunization, and information and coverage straight from the floor of from the ongoing conferences and annual meetings.